|
|
||||||||
The Annals of Thoracic Surgery, Vol 49, 916-919, Copyright © 1990 by The Society of Thoracic Surgeons
FM Ramadan, GR Upchurch Jr, BA Keagy and G Johnson Jr
Vascular endothelium has been established as a major source of prostacyclin
production. Whether endothelial cells are also capable of synthesizing
thromboxane A2 remains controversial. Suppression of such endothelial
thromboxane synthesis would be beneficial for short-term patency of
vascular grafts. This study examined the production of thromboxane A2 by
endothelial cells and its modulation by the calcium- channel blocker
nifedipine in vitro. The results indicate that (1) endothelial cells
spontaneously secrete thromboxane A2, (2) this production can be enhanced
severalfold in the presence of arachidonic acid, and (3) the
calcium-channel blocker nifedipine significantly inhibits thromboxane
production without demonstrable toxicity to the endothelial cells.
ARTICLES
Endothelial cell thromboxane production and its inhibition by a calcium- channel blocker
Department of Surgery, University of North Carolina, Chapel Hill, NC 27599-7210.
This article has been cited by other articles:
![]() |
C. D. Fike and M. R. Kaplowitz Nifedipine inhibits pulmonary hypertension but does not prevent decreased lung eNOS in hypoxic newborn pigs Am J Physiol Lung Cell Mol Physiol, September 1, 1999; 277(3): L449 - L456. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |